Acutus Medical Inc
NASDAQ:AFIB
Acutus Medical Inc
Revenue
Acutus Medical Inc
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Acutus Medical Inc
NASDAQ:AFIB
|
Revenue
$16.4m
|
CAGR 3-Years
79%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Becton Dickinson and Co
NYSE:BDX
|
Revenue
$19.5B
|
CAGR 3-Years
4%
|
CAGR 5-Years
3%
|
CAGR 10-Years
9%
|
|
Boston Scientific Corp
NYSE:BSX
|
Revenue
$14.7B
|
CAGR 3-Years
13%
|
CAGR 5-Years
8%
|
CAGR 10-Years
7%
|
|
Stryker Corp
NYSE:SYK
|
Revenue
$21B
|
CAGR 3-Years
13%
|
CAGR 5-Years
9%
|
CAGR 10-Years
9%
|
|
Abbott Laboratories
NYSE:ABT
|
Revenue
$40.3B
|
CAGR 3-Years
3%
|
CAGR 5-Years
6%
|
CAGR 10-Years
8%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Revenue
$7.3B
|
CAGR 3-Years
17%
|
CAGR 5-Years
14%
|
CAGR 10-Years
13%
|
Acutus Medical Inc
Revenue Breakdown
Breakdown by Geography
Acutus Medical Inc
Total Revenue:
16.4m
USD
|
United States:
8.7m
USD
|
Non-Us:
7.7m
USD
|
Breakdown by Segments
Acutus Medical Inc
See Also
What is Acutus Medical Inc's Revenue?
Revenue
16.4m
USD
Based on the financial report for Dec 31, 2022, Acutus Medical Inc's Revenue amounts to 16.4m USD.
What is Acutus Medical Inc's Revenue growth rate?
Revenue CAGR 3Y
79%
Over the last year, the Revenue growth was -5%. The average annual Revenue growth rates for Acutus Medical Inc have been 79% over the past three years .